Dr. Matthew Ehrhardt is an Associate Member in the Division of Cancer Survivorship at St. Jude Children’s Research Hospital. Dr. Ehrhardt received his medical degree from the University of Illinois College of Medicine at Peoria and completed training in pediatrics, internal medicine, and pediatric hematology/oncology/blood and marrow transplantation at the Medical College of Wisconsin. He completed an additional year of training in childhood cancer survivorship at St. Jude Children’s Research Hospital, following which he joined the faculty and specializes in the care of children newly diagnosed with Hodgkin and non-Hodgkin lymphoma and long-term childhood cancer survivors.
Dr. Ehrhardt’s clinical research is focused on the long-term effects of childhood cancer therapy, in particular cardiac conditions, as well as surveillance guideline development, dissemination, and utilization. He is a member of the American Society of Clinical Oncology Survivorship (ASCO) Guideline Advisory Group, the American College of Radiology (ACR) Appropriateness Criteria Committee, and multiple Children’s Oncology Group (COG) and International Guideline Harmonization Group (IGHG) guideline panels and initiatives, including Co-Chair elect of the COG Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. He is actively seeking mechanisms in which to improve both guideline recommendations and effectiveness of delivery to cancer survivors.
